<i>PDX1</i> DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis
DNA methylation is a crucial epigenetic mechanism for gene expression regulation and cell differentiation. Furthermore, it was found to play a major role in multiple pathological processes, including cancer. In pancreatic neuroendocrine neoplasms (PNENs), epigenetic deregulation is also considered t...
Main Authors: | Gitta Boons, Timon Vandamme, Joe Ibrahim, Geert Roeyen, Ann Driessen, Dieter Peeters, Ben Lawrence, Cristin Print, Marc Peeters, Guy Van Camp, Ken Op de Beeck |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1461 |
Similar Items
-
Cell-Free DNA From Metastatic Pancreatic Neuroendocrine Tumor Patients Contains Tumor-Specific Mutations and Copy Number Variations
by: Gitta Boons, et al.
Published: (2018-11-01) -
NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors
by: Michelle X. Yang, et al.
Published: (2018-04-01) -
Novel monoclonal antibodies against Pdx1 reveal feedback regulation of Pdx1 protein levels
by: T. Galbo, et al.
Published: (2010-04-01) -
Solution Structures and Dynamic Assembly of the 24-Meric Plasmodial Pdx1–Pdx2 Complex
by: Najeeb Ullah, et al.
Published: (2020-08-01) -
Novel codons in rat Pdx-1 complementary DNA
by: Takayoshi Kiba
Published: (2018-10-01)